BSEBoard Meeting3d ago · 29 Aug 2026, 06:02 pm
Submission of outcome of the board meeting.
Novelix Pharmaceuticals Ltd · 536565
✦ AI SummaryMgmt Change
Novelix Pharmaceuticals Ltd has announced the outcome of its board meeting, which was held on August 29, 2026. The board has approved the appointment of Gnana Prakash Gattu as a whole-time director of the company, effective from August 29, 2026. The company has also announced the date of its annual general meeting, which will be held on September 30, 2026.
Analysis Scores
Earnings Impact2/10
Growth Catalyst3/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact5/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Novelix Pharmaceuticals Ltd - 536565 - Board Meeting Outcome for Outcome Of Board Meeting Held On Saturday, 29Th August, 2026
Attachments (1)
📄pdf
Download →
fb8e0015-ef4c-4e5d-b8c1-98b04d18ec40.pdf
View document text
nffi*#kffi,w**
Date: 29tt August, 2026
The Deputy Manager
Department of Corporate Services
BSE Limited
Phiroze Jeejeebhoy Towers,
Dalal Street, Fort,
Mumbai-400001.
Sub: Outcome of Board Meeting held on Saturday, 29th August, 2026 pursuant to
Regulation 30 of SEBI (Listing Obligation and Disclosure Requirements) Regulations,
2015.
Ref: Scrip Code: 586565
Scrip ld: NOVELIX
Respected Sir/ Madam,
This is to inform that Board of Directors of the Company in their meeting held on Saturday,
29th August, 2026 at the registered office of the company i.e. H No: 3-6-237 /610,Flat No: 610.
6Th Floor, Lingapur LA Builders, Also Known as Amrutha Estates, Himayat Nagar,
Hyderabad, Telangana- 500029, which commenced at 3:00 P.M. has Considered and
Approved:
1. The Board Report along with all other necessary Annexure for the financial year ended
March 31, 2026.
The Draft Notice for convening the Annual General Meeting (AGM).
The 32.a Annual General Meeting of the Company to be convened on, Wednesday, 30tt'
September 2026 at 03:00 P.M., through Video ConJerencing/ Other Audio Visual Means
(OAVM) in compliance with the applicable provisions of the Companies Act, 2013 read
with MCA General Circulars in this regard.
4. Closure of the Register of members and share transfer books of the Company from
Thursday 24tn September, 2026 to Wednesday 30th September, 2026 lor holding Annual
General Meeting.
5. Appointment of M/s. Bharat Khaniwal & Co., Practicing Company Secretary
(Membership No.: A29085), as the Scrutinizer to Scrutinize the Voting through "Remote E
voting" and "E- voting during the AGM" for ensuing Annual Genetal Meeting.
Cut-off date for determining the eligibility to vote by electronic means for the purpose of
Annual General Meeting shall be Wednesday 23,4 September, 2026.
The appointment of Gnana Prakash Gattu (DIN:00517921) as Who of the
Company w.e.f. 29rh August, 2026;
The Meeting was concluded at 04:55 P.M. with the vote of thanks.
Novelix Pharmaceuticals Iimited
(Formerly Known as TRI URTHI LllrlTED)
H No: l-6-217/61o, Flat No: 61o, 6rh Floor, Lingapur LA Builders, Also Known as Amrutha Estates, Himayat
Nagar, Hyderabad, Telangana- 5ooo29 Ph No: +9r 8977611o44 Email: novelixpharmaceuti(als@gmail.com
www.novelixpharma.com
\4 gfraxmateuticata
Aloaelin timitut
;lr5'
- (FormerlyTR|MURTH|LtirlTED)CtN:167120TG1994p1C018956
i\ \ I I l\ i.n,c,,i r\l.irllrilrr'li
We request you to take the aforesaid information on record for dissemination through your
website.
Thanking you,
Yours Faithfully,
For Novelix
Venkateshwarlu
(Whole-time
DIN: 02076871
Annexure I
Novelix Pharmaceuticals limited
(Formerly Known as TRI URTHI LllrilTED)
H No: 3-6'217161o, Flat No: 610, 6rh Floor, Lingapur LA Builders, AIso Known as Amrutha Estates, Himayat
Nagar, Hyderabad, Telangana- 5ooo29 Ph No: +91 8977611o44 Email: novelixpharmaceuticats@gmail.com
www.novelixpharma.com
;t *Kff^(kffiffi",w*u,
Details as required as per Regulation 30 of SEBI (LODR) Regulations,20l5 read with
SEBI Master circular no. Hol49ll4l14(7)2025-cFD-poD2fi13762t2026 dated January
30,2026:
Sr. No. Disclosure Requirement Details
I Reason for change viz. Change in Mr. Gnana Prakash Gattu is appointed
Designation as Whole time director of the company
with effect from 29th August, 2026.
2. Date of appointment & 29th August, 2026
Term of Appointment Mr. Gnana Prakash Gattu is appointed
as Whole time director of the company
for a period of 5 years subject to
approval of the members of the
Company in the ensuing annual
general meeting.
J. Name of the listed entities in which Ni1
resigning director holds directorship
including category of directorship
and membership of committee, if any
4. Brief Profile (ln case ofappointment) Mr. Gattu Gnana Prakash is a graduate
from llT-Chennai and having more
than 25 years of experience in
management and information
technology.
5. Disclosure of Relationship between Mr. Gattu Gnana Prakash is not related
Directors {in case of appointment of to any of the Directors or Key
Director) Managerial Personnel.
Mr. Gattu Gnana Prakash belongs to
Promoters and Promoter group of the
Company.
6. Information as required under BSE Mr. Gattu Gnana Prakash is not
circular no. LIST/COMP/1412018- debarred from holding the office of
19. dated June 20, 2018. Director by any SEBI order or any
other such authority.
t"r,\ryffi
Novelix Pharmaceuticals limited
(Forme y Known as TRIMURTHI LllrlITED)
H Not 3-6-2371610, Flat No: 61o, 6rh Floor, Lingapur tA Builders, Also Known as Amrutha Estates, Himayat
Nagar, Hyderabad, Telangana- 5ooo29 Ph No: +91 8977631c44 EmaiL novelixpharmaceuticals@gmait.com
www.novelixpharma.com